Eden Research Plc offers sustainable solutions for crop protection, animal health and consumer products in the United Kingdom and rest of Europe. The company is headquartered in Oxford, Oxfordshire and currently employs 23 full-time employees. The company went IPO on 2012-05-11. The firm develops and supplies biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries. Its products include crop protection, animal health, and consumer products. Its crop protection includes Mevalone and Cedroz. Mevalone is a foliar, contact biofungicide which delivers a controlled release pattern of multiple terpene active ingredients. Cedroz is a terpene-based product developed in conjunction with Eastman Chemical Company as a post-planting solution to the problem of root-knot nematodes. The firm's Sustaine encapsulation technology is used to harness the biocidal activity of naturally occurring molecules produced by plants (terpenes) as part of their defence systems. Sustaine is used in a wide range of applications such as agricultural, animal health and consumer products
Eden Research plc'in temel mali tabloları nelerdir?
Son mali tabloya (Form-10K) göre, Swedish Orphan Biovitrum AB (publ)'in toplam varlıkları $0 olup, net 亏损 $0'dir.
EDNSF'ün temel finansal oranları nelerdir?
Swedish Orphan Biovitrum AB (publ)'in cari oranı 0, net kâr marjı 0, hisse başına satış $0'dir.
Eden Research plc'in geliri segment veya coğrafya bazında nasıl dağılıyor?
Swedish Orphan Biovitrum AB (publ) 最大收入来源是 Haematology,在最近的收益报告中收入为 13,370,000,000。就地区而言, United States 是 Swedish Orphan Biovitrum AB (publ) 的主要市场,收入为 8,148,000,000。
Eden Research plc kârlı mı?
否, son mali tablolara göre Swedish Orphan Biovitrum AB (publ)'in net 亏损 $0'dir.
Eden Research plc'in herhangi bir yükümlülüğü var mı?
否, Swedish Orphan Biovitrum AB (publ)'in yükümlülüğü 0'dir.
Eden Research plc'in tedavüldeki hisse sayısı kaçtır?
Swedish Orphan Biovitrum AB (publ)'in toplam tedavüldeki hisse sayısı 0'dir.